Tissue Engineering Market Size, Share, and Trends 2024 to 2034

The global tissue engineering market size was USD 10.18 billion in 2023, calculated at USD 11.7 billion in 2024 and is expected to reach around USD 36.34 billion by 2034, expanding at a CAGR of 12% from 2024 to 2034.

  • Last Updated : August 2024
  • Report Code : 2268
  • Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Tissue Engineering Market 

5.1. COVID-19 Landscape: Tissue Engineering Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Tissue Engineering Market, By Application

8.1. Tissue Engineering Market, by Application, 2024-2034

8.1.1 Cord blood & Cell Banking

8.1.1.1. Market Revenue and Forecast (2021-2034)

8.1.2. GI, Gynecology

8.1.2.1. Market Revenue and Forecast (2021-2034)

8.1.3. Cancer

8.1.3.1. Market Revenue and Forecast (2021-2034)

8.1.4. Skin & Integumentary

8.1.4.1. Market Revenue and Forecast (2021-2034)

8.1.5. Dental

8.1.5.1. Market Revenue and Forecast (2021-2034)

8.1.6. Orthopedics, Musculoskeletal, & Spine

8.1.6.1. Market Revenue and Forecast (2021-2034)

8.1.7. Neurology

8.1.7.1. Market Revenue and Forecast (2021-2034)

8.1.8. Urology

8.1.8.1. Market Revenue and Forecast (2021-2034)

8.1.9. Cardiology & Vascular

8.1.9.1. Market Revenue and Forecast (2021-2034)

8.1.10. Others

8.1.10.1. Market Revenue and Forecast (2021-2034)

Chapter 9. Global Tissue Engineering Market, By Material Type

9.1. Tissue Engineering Market, by Material Type, 2024-2034

9.1.1. Synthetic Material

9.1.1.1. Market Revenue and Forecast (2021-2034)

9.1.2. Biologically Derived Material

9.1.2.1. Market Revenue and Forecast (2021-2034)

9.1.3. Others

9.1.3.1. Market Revenue and Forecast (2021-2034)

Chapter 10. Global Tissue Engineering Market, By End-Use 

10.1. Tissue Engineering Market, by End-Use, 2024-2034

10.1.1. Regenerative medicine research

10.1.1.1. Market Revenue and Forecast (2021-2034)

10.1.2. Hospitals

10.1.2.1. Market Revenue and Forecast (2021-2034)

10.1.3. Healthcare and medical institutes

10.1.3.1. Market Revenue and Forecast (2021-2034)

10.1.4. Others

10.1.4.1. Market Revenue and Forecast (2021-2034)

Chapter 11. Global Tissue Engineering Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Forecast, by Application (2021-2034)

11.1.2. Market Revenue and Forecast, by Material Type (2021-2034)

11.1.3. Market Revenue and Forecast, by End-Use (2021-2034)

11.1.4. U.S.

11.1.4.1. Market Revenue and Forecast, by Application (2021-2034)

11.1.4.2. Market Revenue and Forecast, by Material Type (2021-2034)

11.1.4.3. Market Revenue and Forecast, by End-Use (2021-2034)

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Forecast, by Application (2021-2034)

11.1.5.2. Market Revenue and Forecast, by Material Type (2021-2034)

11.1.5.3. Market Revenue and Forecast, by End-Use (2021-2034)

11.2. Europe

11.2.1. Market Revenue and Forecast, by Application (2021-2034)

11.2.2. Market Revenue and Forecast, by Material Type (2021-2034)

11.2.3. Market Revenue and Forecast, by End-Use (2021-2034)

11.2.4. UK

11.2.4.1. Market Revenue and Forecast, by Application (2021-2034)

11.2.4.2. Market Revenue and Forecast, by Material Type (2021-2034)

11.2.4.3. Market Revenue and Forecast, by End-Use (2021-2034)

11.2.5. Germany

11.2.5.1. Market Revenue and Forecast, by Application (2021-2034)

11.2.5.2. Market Revenue and Forecast, by Material Type (2021-2034)

11.2.5.3. Market Revenue and Forecast, by End-Use (2021-2034)

11.2.6. France

11.2.6.1. Market Revenue and Forecast, by Application (2021-2034)

11.2.6.2. Market Revenue and Forecast, by Material Type (2021-2034)

11.2.6.3. Market Revenue and Forecast, by End-Use (2021-2034)

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Forecast, by Application (2021-2034)

11.2.7.2. Market Revenue and Forecast, by Material Type (2021-2034)

11.2.7.3. Market Revenue and Forecast, by End-Use (2021-2034)

11.3. APAC

11.3.1. Market Revenue and Forecast, by Application (2021-2034)

11.3.2. Market Revenue and Forecast, by Material Type (2021-2034)

11.3.3. Market Revenue and Forecast, by End-Use (2021-2034)

11.3.4. India

11.3.4.1. Market Revenue and Forecast, by Application (2021-2034)

11.3.4.2. Market Revenue and Forecast, by Material Type (2021-2034)

11.3.4.3. Market Revenue and Forecast, by End-Use (2021-2034)

11.3.5. China

11.3.5.1. Market Revenue and Forecast, by Application (2021-2034)

11.3.5.2. Market Revenue and Forecast, by Material Type (2021-2034)

11.3.5.3. Market Revenue and Forecast, by End-Use (2021-2034)

11.3.6. Japan

11.3.6.1. Market Revenue and Forecast, by Application (2021-2034)

11.3.6.2. Market Revenue and Forecast, by Material Type (2021-2034)

11.3.6.3. Market Revenue and Forecast, by End-Use (2021-2034)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Forecast, by Application (2021-2034)

11.3.7.2. Market Revenue and Forecast, by Material Type (2021-2034)

11.3.7.3. Market Revenue and Forecast, by End-Use (2021-2034)

11.4. MEA

11.4.1. Market Revenue and Forecast, by Application (2021-2034)

11.4.2. Market Revenue and Forecast, by Material Type (2021-2034)

11.4.3. Market Revenue and Forecast, by End-Use (2021-2034)

11.4.4. GCC

11.4.4.1. Market Revenue and Forecast, by Application (2021-2034)

11.4.4.2. Market Revenue and Forecast, by Material Type (2021-2034)

11.4.4.3. Market Revenue and Forecast, by End-Use (2021-2034)

11.4.5. North Africa

11.4.5.1. Market Revenue and Forecast, by Application (2021-2034)

11.4.5.2. Market Revenue and Forecast, by Material Type (2021-2034)

11.4.5.3. Market Revenue and Forecast, by End-Use (2021-2034)

11.4.6. South Africa

11.4.6.1. Market Revenue and Forecast, by Application (2021-2034)

11.4.6.2. Market Revenue and Forecast, by Material Type (2021-2034)

11.4.6.3. Market Revenue and Forecast, by End-Use (2021-2034)

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Forecast, by Application (2021-2034)

11.4.7.2. Market Revenue and Forecast, by Material Type (2021-2034)

11.4.7.3. Market Revenue and Forecast, by End-Use (2021-2034)

11.5. Latin America

11.5.1. Market Revenue and Forecast, by Application (2021-2034)

11.5.2. Market Revenue and Forecast, by Material Type (2021-2034)

11.5.3. Market Revenue and Forecast, by End-Use (2021-2034)

11.5.4. Brazil

11.5.4.1. Market Revenue and Forecast, by Application (2021-2034)

11.5.4.2. Market Revenue and Forecast, by Material Type (2021-2034)

11.5.4.3. Market Revenue and Forecast, by End-Use (2021-2034)

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Forecast, by Application (2021-2034)

11.5.5.2. Market Revenue and Forecast, by Material Type (2021-2034)

11.5.5.3. Market Revenue and Forecast, by End-Use (2021-2034)

Chapter 12. Company Profiles

12.1. Stryker Corporation

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Organogenesis Inc

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. Cook Biotech Inc

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. Integra Life Sciences Corporation

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. 3M

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. AbbVie Inc.

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Medtronic

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. Zimmer Biomet

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. Baxter International Inc.

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. DePuy Synthes (Johnson & Johnson Services, Inc.)

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client